461 related articles for article (PubMed ID: 16497404)
1. Tumor-induced lymphangiogenesis: a target for cancer therapy?
Thiele W; Sleeman JP
J Biotechnol; 2006 Jun; 124(1):224-41. PubMed ID: 16497404
[TBL] [Abstract][Full Text] [Related]
2. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
3. Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats.
Krishnan J; Kirkin V; Steffen A; Hegen M; Weih D; Tomarev S; Wilting J; Sleeman JP
Cancer Res; 2003 Feb; 63(3):713-22. PubMed ID: 12566318
[TBL] [Abstract][Full Text] [Related]
4. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
[TBL] [Abstract][Full Text] [Related]
5. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO
Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000
[TBL] [Abstract][Full Text] [Related]
6. Pathways targeting tumor lymphangiogenesis.
Wissmann C; Detmar M
Clin Cancer Res; 2006 Dec; 12(23):6865-8. PubMed ID: 17145802
[TBL] [Abstract][Full Text] [Related]
7. Expression of vascular endothelial growth factor C (VEGF-C) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis.
Jennbacken K; Vallbo C; Wang W; Damber JE
Prostate; 2005 Oct; 65(2):110-6. PubMed ID: 15880525
[TBL] [Abstract][Full Text] [Related]
8. Lymphangiogenesis, inflammation and metastasis.
Schoppmann SF
Anticancer Res; 2005; 25(6C):4503-11. PubMed ID: 16334134
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
[TBL] [Abstract][Full Text] [Related]
10. The relationship between tumors and the lymphatics: what more is there to know?
Sleeman JP
Lymphology; 2006 Jun; 39(2):62-8. PubMed ID: 16910096
[TBL] [Abstract][Full Text] [Related]
11. [Lymphangiogenes and location of tumor lymphatic vessels induced by VEGF-C in primary breast carcer].
Huang JH; Li Y; Liu L; Yang HC; Hai J; Tang LL; Hu TH
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):36-9, 51. PubMed ID: 16562672
[TBL] [Abstract][Full Text] [Related]
12. Tumor and lymph node lymphangiogenesis--impact on cancer metastasis.
Tobler NE; Detmar M
J Leukoc Biol; 2006 Oct; 80(4):691-6. PubMed ID: 16793912
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor-a promotes peritumoral lymphangiogenesis and lymphatic metastasis.
Björndahl MA; Cao R; Burton JB; Brakenhielm E; Religa P; Galter D; Wu L; Cao Y
Cancer Res; 2005 Oct; 65(20):9261-8. PubMed ID: 16230387
[TBL] [Abstract][Full Text] [Related]
14. Correlation between lymph node metastasis and the expression of VEGF-C, VEGF-D and VEGFR-3 in T1 lung adenocarcinoma.
Maekawa S; Iwasaki A; Shirakusa T; Enatsu S; Kawakami T; Kuroki M; Kuroki M
Anticancer Res; 2007; 27(6A):3735-41. PubMed ID: 17970036
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoids suppress tumor lymphangiogenesis of prostate cancer cells.
Yano A; Fujii Y; Iwai A; Kawakami S; Kageyama Y; Kihara K
Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6012-7. PubMed ID: 17062674
[TBL] [Abstract][Full Text] [Related]
16. Lymphangiogenic growth factors as markers of tumor metastasis.
Stacker SA; Williams RA; Achen MG
APMIS; 2004; 112(7-8):539-49. PubMed ID: 15563315
[TBL] [Abstract][Full Text] [Related]
17. Expression pattern of the lymphatic and vascular markers VEGFR-3 and CD31 does not predict regional lymph node metastasis in cutaneous melanoma.
Wobser M; Siedel C; Schrama D; Bröcker EB; Becker JC; Vetter-Kauczok CS
Arch Dermatol Res; 2006 Feb; 297(8):352-7. PubMed ID: 16395613
[TBL] [Abstract][Full Text] [Related]
18. Lymphangiogenesis and tumor metastasis: myth or reality?
Pepper MS
Clin Cancer Res; 2001 Mar; 7(3):462-8. PubMed ID: 11297234
[TBL] [Abstract][Full Text] [Related]
19. Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis.
Zeng Y; Opeskin K; Goad J; Williams ED
Cancer Res; 2006 Oct; 66(19):9566-75. PubMed ID: 17018613
[TBL] [Abstract][Full Text] [Related]
20. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis.
Skobe M; Hawighorst T; Jackson DG; Prevo R; Janes L; Velasco P; Riccardi L; Alitalo K; Claffey K; Detmar M
Nat Med; 2001 Feb; 7(2):192-8. PubMed ID: 11175850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
